Preventive hiv vaccine acceptability and behavioral risk compensation among a random sample of high-risk adults in los angeles (La voices): Research briefs

Health Services Research

Volumn 44, Issue 6, 2009, Pages 2167-2179

  Newman, Peter A ^f   Lee, Sung Jae ^a   Duan, Naihua ^b   Rudy, Ellen ^c   Nakazono, Terry K ^d   Boscardin, John ^a   Kakinami, Lisa ^e   Shoptaw, Steven ^d   Diamant, Allison ^d   Cunningham, William E ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c LOS ANGELES COUNTY DEPARTMENT OF HEALTH SERVICES   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF ROCHESTER   (United States)

^f University of Rochester ^*

Author keywords

AIDS; Conjoint analysis; HIV; HIV vaccine; Risk compensation; Venue based probability sampling

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; ROTAVAX; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BEHAVIOR; COMMUNITY PROGRAM; COMPENSATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG COST; DRUG EFFICACY; ETHNIC GROUP; FEMALE; HEALTH CARE COST; HEALTH PROGRAM; HEALTH SERVICE; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROBABILITY; RANDOM SAMPLE; SEX RATIO; STRUCTURED INTERVIEW; TREATMENT RESPONSE; UNITED STATES; VACCINATION; VACCINATION REACTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AIDS VACCINES; CROSS-SECTIONAL STUDIES; FEMALE; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; LOS ANGELES; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; RISK-TAKING; UNSAFE SEX; YOUNG ADULT;

EID: 72849136082     PISSN: 00179124     EISSN: 14756773     Source Type: Journal    
DOI: 10.1111/j.1475-6773.2009.01039.x     Document Type: Article

References (29)

1. Allen, M. C. Y. Lau. 2008 Social Impact of Preventive HIV Vaccine Clinical Trial Participation: A Model of Prevention, Assessment and Intervention Social Science and Medicine 66 (4) : 945 951.
2. Blower, S., E. J. Schwartz J. Mills. 2003 Forecasting the Future of HIV Epidemics: The Impact of Antiretroviral Therapies and Imperfect Vaccines AIDS Reviews 5 (2) : 113 125.
3. Cohen, J. 2006 Gates Foundation Doubled Support for HIV Vaccine Research Science 313 (5785) : 283.
4. Colfax, G., S. Buchbinder, G. Vamshidar, C. Celum, D. McKirnan, J. Neidig, B. Koblin, M. Gurwith B. Bartholow. 2005 Motivations for Participating in an HIV Vaccine Efficacy Trial Journal of Acquired Immune Deficiency Syndromes 39 (3) : 359 364.
5. Cunningham, W. E., R. D. Hays, N. Duan, R. Andersen, T. T. Nakazono, S. A. Bozzette M. F. Shapiro. 2005 The Effect of Socioeconomic Status on the Survival of People Receiving Care for HIV Infection in the United States Journal of Health Care for the Poor and Underserved 16 (4) : 655 676.
6. Danovaro-Holliday, M. C., A. L. Wood C. W. LeBaron. 2002 Rotavirus Vaccine and the News Media, 1987-2001 Journal of the American Medical Association 287 (11) : 1455 1462.
7. Duan, N., D. F. McCaffrey, M. R. Frankel, P. A. Clair, R. Beckman, J. W. Keesey, S. Chien, D. P. Goldman, S. M. Smith, S. A. Bozzette, S. H. Berry, J. A. Brown, J. F. Perlman, M. Shapiro S. C. Morton. 1999. HCSUS Baseline Methods Technical Report: Weighting, Imputation and Variance Estimation. RAND Report MR-1060-AHCPR. Santa Monica, CA.
8. Esparza, J., M. L. Chang, R. Widdus, Y. Madrid, N. Walker P. D. Ghys. 2003 Estimation of 'Needs' and 'Probable Uptake' for HIVAIDS Preventive Vaccines Based on Possible Policies and Likely Acceptance (a WHOUNAIDSIAVI Study) Vaccine 21 (17-18) : 2032 2041.
9. Green, P. E. V. Srinivasan. 1978 Conjoint Analysis in Consumer Research: Issues and Outlook Journal of Consumer Research 5 (2) : 103 123.
10. Hall, H. I., R. Song, P. Rhodes, J. Prejean, Q. An, L. M. Lee, J. Karon, R. Brookmeyer, E. H. Kaplan, M. T. McKenna, R. S. Janssen for the HIV Incidence Surveillance Group. 2008 Estimation of HIV Incidence in the United States Journal of the American Medical Association 300 (5) : 520 529.
11. Hay, J. 2002 Conjoint Analysis in Pharmaceutical Research Journal of Managed Care Pharmacy 8 (3) : 206 208.
12. Hecht, R. C. Suraratdecha. 2006 Estimating the Demand for a Preventive HIV Vaccine: Why We Need to Do Better. Reliable Estimates Would Help in Achieving Sveral Policy and Advocacy Objectives PloS Medicine 3 (10) : e398.
13. IAVI. 2009. "Database of AIDS Vaccines in Clinical Trials. IAVI" [accessed on June 29, 2009]. Available at
14. Kish, L. M. R. Frankel. 1974 Inference from Complex Samples Journal of the Royal Statistical Society, Series B 36 : 1 37.
15. Mills, E., C. Cooper, G. Guyatt, A. Gilchrist, B. Rachlis, C. Sulway K. Wilson. 2004 Barriers in Participating in an HIV Vaccine Trial: A Systematic Review AIDS 18 (17) : 2235 2242.
16. Newman, P. A. 2006 Towards a Science of Community Engagement Lancet 367 (9507) : 302.
17. Newman, P. A., A. Daley, R. Halpenny M. Loutfy. 2008 Community Heroes or "High-Risk" Pariahs? Reasons for Declining to Enroll in an HIV Vaccine Trial Vaccine 26 (8) : 1091 1097.
18. Newman, P. A., N. Duan, S.-J. Lee, E. T. Rudy, D. S. Seiden, L. Kakinami W. E. Cunningham. 2006 HIV Vaccine Acceptability among Communities at Risk: The Impact of Vaccine Characteristics Vaccine 24 (12) : 2094 2101.
19. Newman, P. A., N. Duan, E. T. Rudy P. A. Anton. 2004a Challenges for HIV Vaccine Dissemination and Clinical Trial Recruitment: If We Build It, Will They Come? AIDS Patient Care and STDS 18 (12) : 691 701.
20. Newman, P. A., N. Duan, E. T. Rudy, K. J. Roberts D. Swendeman. 2004b Posttrial HIV Vaccine Adoption: Concerns, Motivators, and Intentions among Persons at Risk for HIV Journal of Acquired Immune Deficiency Syndromes 37 (3) : 1393 1403.
21. Newman, P. A., D. S. Seiden, K. J. Roberts, L. Kakinami N. Duan. 2009 A Small Dose of HIV? HIV Vaccine Mental Models and Risk Communication Health Education and Behavior 36 (2) : 321 333.
22. NOVA Research Company. 2003. Questionnaire Development System (release 2.1) Statistical Software. Bethesda, MD : NOVA Research Company.
23. Padian, N. S., A. Buvé, J. Balkus, D. Serwadda W. Jr. Cates. 2008 Biomedical Interventions to Prevent HIV Infection: Evidence, Challenges, and Way Forward Lancet 372 (9638) : 585 599.
24. Plackett, R. L. J. P. Burman. 1946 The Design of Optimum Multifactorial Experiments Biometrika Trust 33 (4) : 305 325.
25. Ryan, M. S. Farrar. 2000 Using Conjoint Analysis to Elicit Preferences for Health Care British Medical Journal 320 (7248) : 1530 1533.
26. Simon, P. A., D. J. Hu, T. Diaz P. R. Kerndt. 1995 Income and AIDS Rates in Los Angeles County AIDS 9 (3) : 281 284.
27. Stacy, A. W., M. D. Newcomb S. L. Ames. 2000 Implicit Cognition and HIV Risk Behavior Journal of Behavioral Medicine 23 (5) : 475 499.
28. Stover, J., L. Bollinger, R. Hecht, C. Williams E. Roca. 2007 The Impact of an AIDS Vaccine in Developing Countries: A New Model and Initial Results Health Affairs 26 (4) : 1147 1158.
29. UNAIDS. 2006. "Global Facts and Figures." [accessed on June 29, 2009]. Available at